Intermittent pressure overload triggers hypertrophy-independent cardiac dysfunction and vascular rarefaction

被引:206
作者
Perrino, Cinzia
Prasad, Sathyamangla V. Naga
Mao, Lan
Noma, Takahisa
Yan, Zhen
Kim, Hyung-Suk
Smithies, Oliver
Rockman, Howard A.
机构
[1] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA
[2] Univ N Carolina, Chapel Hill, NC USA
关键词
D O I
10.1172/JCI25397
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
For over a century, there has been intense debate as to the reason why some cardiac stresses are pathological and others are physiological. One long-standing theory is that physiological overloads such as exercise are intermittent, while pathological overloads such as hypertension are chronic. In this study, we hypothesized that the nature of the stress on the heart, rather than its duration, is the key determinant of the maladaptive phenotype. To test this, we applied intermittent pressure overload on the hearts of mice and tested the roles of duration and nature of the stress on the development of cardiac failure. Despite a mild hypertrophic response, preserved systolic function, and a favorable fetal gene expression profile, hearts exposed to intermittent pressure overload displayed pathological features. Importantly, intermittent pressure overload caused diastolic dysfunction, altered beta-adrenergic receptor (beta AR) function, and vascular rarefaction before the development of cardiac hypertrophy, which were largely normalized by preventing the recruitment of PI3K by beta AR kinase 1 to ligand-activated receptors. Thus stress-induced activation of pathogenic signaling pathways, not the duration of stress or the hypertrophic growth per se, is the molecular trigger of cardiac dysfunction.
引用
收藏
页码:1547 / 1560
页数:14
相关论文
共 54 条
[1]   Skeletal muscle adaptation in response to voluntary running in Ca2+/calmodulin-dependent protein kinase IV-deficient mice [J].
Akimoto, T ;
Ribar, TJ ;
Williams, RS ;
Yan, Z .
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 2004, 287 (05) :C1311-C1319
[2]   Fas receptor signaling inhibits glycogen synthase kinase 3β and induces cardiac hypertrophy following pressure overload [J].
Badorff, C ;
Ruetten, H ;
Mueller, S ;
Stahmer, M ;
Gehring, D ;
Jung, F ;
Ihling, C ;
Zeiher, AM ;
Dimmeler, S .
JOURNAL OF CLINICAL INVESTIGATION, 2002, 109 (03) :373-381
[3]   Melusin, a muscle-specific integrin β1-interacting protein, is required to prevent cardiac failure in response to chronic pressure overload [J].
Brancaccio, M ;
Fratta, L ;
Notte, A ;
Hirsch, E ;
Poulet, R ;
Guazzone, S ;
De Acetis, M ;
Vecchione, C ;
Marino, G ;
Altruda, F ;
Silengo, L ;
Tarone, G ;
Lembo, G .
NATURE MEDICINE, 2003, 9 (01) :68-75
[4]   The MEK1-ERK1/2 signaling pathway promotes compensated cardiac hypertrophy in transgenic mice [J].
Bueno, OF ;
De Windt, LJ ;
Tymitz, KM ;
Witt, SA ;
Kimball, TR ;
Klevitsky, R ;
Hewett, TE ;
Jones, SP ;
Lefer, DJ ;
Peng, CF ;
Kitsis, RN ;
Molkentin, JD .
EMBO JOURNAL, 2000, 19 (23) :6341-6350
[5]   Defective β-adrenergic receptor signaling precedes the development of dilated cardiomyopathy in transgenic mice with calsequestrin overexpression [J].
Cho, MC ;
Rapacciuolo, A ;
Koch, WJ ;
Kobayashi, Y ;
Jones, LR ;
Rockman, HA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (32) :22251-22256
[6]   Mechanism of beta-adrenergic receptor desensitization in cardiac hypertrophy is increased beta-adrenergic receptor kinase [J].
Choi, DJ ;
Koch, WJ ;
Hunter, JJ ;
Rockman, HA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (27) :17223-17229
[7]   SYMPATHETIC NERVOUS ACTIVITY DURING EXERCISE [J].
CHRISTENSEN, NJ ;
GALBO, H .
ANNUAL REVIEW OF PHYSIOLOGY, 1983, 45 :139-153
[8]   Regulation of myocardial contractility and cell size by distinct PI3K-PTEN signaling pathways [J].
Crackower, MA ;
Oudit, GY ;
Kozieradzki, I ;
Sarao, R ;
Sun, H ;
Sasaki, T ;
Hirsch, E ;
Suzuki, A ;
Shioi, T ;
Irie-Sasaki, J ;
Sah, R ;
Cheng, HYM ;
Rybin, VO ;
Lembo, G ;
Fratta, L ;
Oliveira-dos-Santos, AJ ;
Benovic, JL ;
Kahn, CR ;
Izumo, S ;
Steinberg, SF ;
Wymann, MP ;
Backx, PH ;
Penninger, JM .
CELL, 2002, 110 (06) :737-749
[9]   Prognostic significance of left ventricular mass change during treatment of hypertension [J].
Devereux, RB ;
Wachtell, K ;
Gerdts, E ;
Boman, K ;
Nieminen, MS ;
Papademetriou, V ;
Rokkedal, J ;
Harris, K ;
Aurup, P ;
Dahlöf, B .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 292 (19) :2350-2356
[10]   Myocyte recovery after mechanical circulatory support in humans with end-stage heart failure [J].
Dipla, K ;
Mattiello, JA ;
Jeevanandam, V ;
Houser, SR ;
Margulies, KB .
CIRCULATION, 1998, 97 (23) :2316-2322